Clinical trial
Beta-2 Polymorphisms and Beta Receptor Selectivity
NCT00214318 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00214318 |
|---|---|
| Title | Beta-2 Polymorphisms and Beta Receptor Selectivity |
| Official title | The Effects of ß2 Polymorphisms on Beta Selectivity After ß-adrenergic Blockade in Patients With Heart Failure |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Drug |
| Interventions | Terbutaline plus Metoprolol or carvedilol |
| Enrollment | 25 |
| Start date | Jan 1, 2005 |
| Completion | Feb 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 8, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: